本網站使用瀏覽器紀錄 (Cookies) 來提供您最好的使用體驗，我們使用的 Cookie 也包括了第三方 Cookie。相關資訊請訪問我們的隱私權與 Cookie 政策。如果您選擇繼續瀏覽或關閉這個提示，便表示您已接受我們的網站使用條款。 關閉
WENZHOU, China, Aug. 13, 2024 /PRNewswire/ -- ZK International Group Co., Ltd. (ZKIN) ("ZK International" or the "Company"), a designer, engineer, manufacturer, and supplier of patented high-performance stainless steel and carbon steel pipe products primarily used for water and gas supplies, today announced its audited financial results for the fiscal year ended September 30, 2023. Financial Highlights for the Fiscal Year 2023 For the Fiscal Year EndedSeptember 30, ($ millions, except per share data) 2023 2022 % Change Revenue $ 111.60 $ 102.39 8.99 % Gross profit $ 1.30 $ 7.60 -82.93 % Gross margin 1.16 % 7.42 % -6.26percentage points Loss from operations $ (60.44) $ (3.96) -1424.58 % Operating loss margin (54.16 %) (3.87 %) -50.29percentagepoints Net loss attributable to ZK International $ (61.06) $ (6.08) -904.06 % Diluted loss per share $ (1.94) $ (0.21) -835.72 % Net book value per share $ 0.80 $ 2.80 -71.43 % Revenue Revenues increased by $9.21 million or 8.99%, to $111.60 million for the year ended September 30, 2023 from $102.39 million for the year ended September 30, 2022. The increase in revenues was primarily driven by the following factors: 1) During the fiscal year 2023, the decline of real estate market in China, especially the collapse of Evergrande, has set pressure on the steel pipe market. To strengthen the cash flow and expand our market share, we lowered our weighted average selling price ("ASP") to boost our sales volume. However, we have observed the recovery of real estate market and increase of market demand for the 2024 fiscal year, we have increased ASP for the 2024 fiscal year. 2) During 2023 fiscal year, the average selling price of electrolytic nickel increased by 33.33% from RMB 113,716 per ton in fiscal year 2022 to RMB 151,619 in fiscal year 2023; the average selling price of steel strip decreased by 1.82% from RMB 20.3 per kilogram in fiscal year 2022 to RMB 19.93 in fiscal year 2023; the average selling price of steel pipe decreased by 20.25% from RMB 140.26 per piece in fiscal year 2022 to RMB 111.86 in fiscal year 2023; the average selling price of pipe fittings decreased by 4.86% from RMB 22.65 each in fiscal year 2022 to RMB 21.55 in fiscal year 2023. 3) Due to the decrease of product prices, we had an overall increase in sales volume. The sales volume of steel strip increased by 87.73% from 753.91 tons in fiscal year 2022 to 1,415.29 tons in fiscal year 2023; Sales volume of pipes increased by 0.42% from 592,919 in fiscal year 2022 to 595,395 in fiscal year 2023; The sales volume of pipe fittings increased by 29.28% from 7,103,894 pieces in fiscal year 2022 to 9,183,690 pieces in fiscal year 2023. Gross Profit Our gross profit decreased by $6.30 million or 82.93% to $1.30 million for the year ended September 30, 2023 from $7.60 million for the year ended September 30, 2022. Gross profit margin was 1.16% for the year ended September 30, 2023, as compared to 7.42% for the year ended September 30, 2022. The decrease of gross profit was primarily due to decreased weighted average selling prices while our cost of raw material remained stable. However, we have observed the recovery of real estate market and increase of market demand for the 2024 fiscal year, we have increased ASP for the 2024 fiscal year which will improve our gross margin. Loss from Operations Loss from operations was $60.44 million, compared to loss from operations of $3.96 million for the prior fiscal year. The increase of operational loss was mainly due to the one-off asset impairment cost of intangible asset and long-term investment, and stock-based compensation incurred during 2023 fiscal year for the expenses related to our new business operations and subsidiaries. During 2023 fiscal year, the Company recorded asset impairment cost of $53.20 million, primarily for the write off of its long-term investment in CG Malta and the software platforms, including xSigma Trading, MaximNFT, and the Defi Exchange. For the 2021 and 2022 fiscal years, CG Malta achieved high growth with its online gaming services launched in more than 10 states in US with high growth rate of Real Money Handle and First-Time Depositor. However, during the 2023 fiscal year, the competition of gaming market has been increasingly intense. Market bullishness and valuations peaked in early-2023 and declined rapidly from there, preventing CG Malta from raising further capital to execute its business plan. For the best interest of the Company's shareholder, the Company decided to stop funding CG Malta and instead demanded the management team of CG Malta took active measures to achieve organic growth and healthy cash flow. However, the business was unable to raise the capital required to fund the business plan, and therefore the shareholders of CG Malta passed shareholder resolution on November 27, 2023 to cease operations of CG Malta and wind up the entity. For the year ended September 30, 2023, the Company has written off the investment in CG Malta. During 2023 fiscal year, the Company evaluated the recoverability of the three platforms, including Defi Exchange, xSigma Trading, and MaximNFT and concluded that the carrying value of the three platforms may not be recoverable as it projects that the platform is likely to have continuing losses and it's more likely than not this platform will be sold or otherwise disposed of significantly before the end of its previously estimated useful life. For the year ended September 30, 2023, the Company wrote off the carrying value of the three platforms. Net Loss Attributable to ZK International Net loss attributable to ZK International was $61.06 million, or net loss of $1.94 per share. This compared to net loss attributable to ZK International of $6.08 million, or $0.21 per share, for the prior fiscal year. Net book value Net book value per share was $0.80 as of September 30, 2023, compared to $2.80 as of September 30, 2022. Mr. Jiancong Huang, Chairman of ZK International, commented, "while ZK International declared a net loss of $61 million for the year, this was largely due to a series of one-time write-offs related to various non-core investments. These write-offs are part of the company's broader strategy to streamline operations and focus on high-growth opportunities, ensuring a more robust financial foundation for the future." Mr. Huang continued, "While this year's financial results reflect certain challenges, I am proud of the progress we have made in growing our revenue and strengthening our core business in China. The strategic decisions we've taken to write off certain investments position us for a more focused and profitable future. We remain committed to enhancing shareholder value and driving long-term growth for ZK International. As ZK International moves forward, the company remains confident in its ability to navigate the evolving market landscape and deliver sustainable value to its shareholders." About ZK International Group Co., Ltd. ZK International Group Co., Ltd. is a China-based designer, engineer, manufacturer, and supplier of patented high-performance stainless steel and carbon steel pipe products that require sophisticated water or gas pipeline systems. The Company owns 33 patents, 21 trademarks, 2 Technical Achievement Awards, and 10 National and Industry Standard Awards. ZK International is Quality Management System Certified (ISO9001), Environmental Management System Certified (ISO1401), and a National Industrial Stainless Steel Production Licensee that is focused on supplying steel piping for the multi-billion dollar industries of Gas and Water sectors. ZK has supplied stainless steel pipelines for over 2,000 projects, including the Beijing National Airport, the "Water Cube", and "Bird's Nest", which were venues for the 2008 Beijing Olympics. Emphasizing superior properties and durability of its steel piping, ZK International is providing a solution for the delivery of high quality, highly sustainable, environmentally sound drinkable water not only to the China market but also to international markets such as Europe, East Asia, and Southeast Asia. For more information please visit www.ZKInternationalGroup.com. Additionally, please follow the Company on Twitter, Facebook, YouTube, and Weibo. For further information on the Company's SEC filings please visit www.sec.gov. Safe Harbor Statement This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. Without limiting the generality of the foregoing, words such as "may," "will," "expect," "believe," "anticipate," "intend," "could," "estimate" or "continue" or the negative or other variations thereof or comparable terminology are intended to identify forward-looking statements. In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances are forward-looking statements. These forward-looking statements are not guarantee of future performance and are subject to certain risks, uncertainties, and assumptions that are difficult to predict and many of which are beyond the control of ZK International. Actual results may differ from those projected in the forward-looking statements due to risks and uncertainties, as well as other risk factors that are included in the Company's filings with the U.S. Securities and Exchange Commission. Although ZK International believes that the assumptions underlying the forward-looking statements are reasonable, any of the assumptions could prove inaccurate and, therefore, there can be no assurance that the results contemplated in forward-looking statements will be realized. In light of the significant uncertainties inherent in the forward-looking information included herein, the inclusion of such information should not be regarded as a representation by ZK International or any other person that their objectives or plans will be achieved. ZK International does not undertake any obligation to revise the forward-looking statements contained herein to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. ZK INTERNATIONAL GROUP CO., LTD CONSOLIDATED BALANCE SHEETS (IN U.S. DOLLARS) As of September 30, 2023 2022 Assets Current assets Cash and cash equivalents $ 4,994,411 $ 7,515,147 Restricted cash 50,995 101,992 Short-term Investment 48,145 915,616 Accounts receivable, net of allowance for doubtful accounts and provision for expected credit loss of $6,617,485 and $255,322, respectively 14,967,186 28,362,933 Notes receivable 54,825 49,611 Prepayment, deposit and other receivable - current 383,413 2,360,539 Inventories 17,937,425 21,141,501 Advance to suppliers 4,810,044 6,322,592 Total current assets 43,246,444 66,769,931 Property, plant and equipment, net 7,836,017 7,124,587 Right-of-use asset – Operating lease 43,840 30,998 Intangible assets, net 1,437,384 11,415,451 Deferred tax assets — 320,164 Prepayment, deposit and other receivable - Non-current 292,070 — Long-term prepayment — 10,447,395 Long-term accounts receivable 5,527,682 7,522,188 Long-term investment 285,540 25,292,866 TOTAL ASSETS $ 58,668,977 $ 128,923,580 LIABILITIES AND SHAREHOLDERS' EQUITY Current liabilities: Accounts payable $ 2,611,220 $ 10,066,758 Accrued expenses and other current liabilities 4,964,893 6,949,772 Operating lease liability - current 21,749 10,754 Accrued payroll and welfare 1,918,415 1,880,377 Advance from customers 821,694 1,758,800 Due to related parties 1,111,001 2,052,403 Convertible debentures 4,011,224 3,352,311 Bank borrowings - current 9,388,706 16,257,820 Notes payables 41,118 702,889 Income tax payable 669 817,059 Total current liabilities 24,890,689 43,848,943 Operating lease liability – non-current 11,811 10,256 Bank borrowings – non-current 8,527,686 — TOTAL LIABILITIES $ 33,430,186 $ 43,859,199 COMMITMENTS AND CONTINGENCIES — — Equity Common stock, no par value, 50,000,000 shares authorized, 32,992,740 and 30,392,940 shares issued and outstanding, respectively Additional paid-in capital 72,886,898 70,872,765 Statutory surplus reserve 3,176,556 3,176,556 Subscription receivable (125,000) (125,000) Retained earnings (Deficits) (47,666,657) 13,394,137 Accumulated other comprehensive loss (3,190,985) (2,640,753) Total equity attributable to ZK International Group Co., Ltd. 25,080,812 84,677,705 Equity attributable to non-controlling interests 157,980 386,676 Total equity 25,238,792 85,064,381 TOTAL LIABILITIES AND EQUITY $ 58,668,977 $ 128,923,580 ZK INTERNATIONAL GROUP CO., LTD CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) (IN U.S. DOLLARS, EXCEPT SHARE DATA) For the year ended September 30, 2023 2022 2021 Revenues $ 111,599,686 $ 102,391,636 $ 99,407,217 Cost of sales (110,303,270) (94,796,037) (92,936,029) Gross profit 1,296,416 7,595,599 6,471,188 Operating expenses: Selling and marketing expenses 2,117,810 2,380,429 3,117,906 General and administrative expenses 5,144,340 5,421,575 5,772,710 Asset impairment loss 53,203,517 2,771,019 — Research and development costs 1,274,337 987,186 1,234,161 Total operating expenses 61,740,004 11,560,209 10,124,777 Operating loss (60,443,588) (3,964,610) (3,653,589) Other income (expenses): Interest expenses (1,583,734) (3,451,665) (1,196,648) Interest income 36,699 109,290 13,733 Income on investment — — 50,649 Other income (expense), net 240,378 (88,125) 431,438 Total other expenses, net (1,306,657) (3,430,500) (700,828) Loss before income taxes (61,750,245) (7,395,110) (4,354,417) Income tax recovery 459,855 1,340,844 552,146 Net loss $ (61,290,390) $ (6,054,266) $ (3,802,271) Net (loss) income attributable to non-controlling interests 229,596 (27,147) 2,757 Net loss attributable to ZK International Group Co., Ltd. (61,060,794) (6,081,413) $ (3,799,514) Net loss (61,290,390) $ (6,054,266) $ (3,802,271) Other comprehensive income (loss): Foreign currency translation adjustment (549,332) (5,504,385) 2,423,439 Total comprehensive loss $ (61,839,722) $ (11,558,651) $ (1,378,832) Comprehensive loss (income) attributable to non-controlling interests 228,696 (62,109) (14,773) Comprehensive loss attributable to ZK International Group Co., Ltd. $ (61,611,026) $ (11,620,760) $ (1,393,605) Basic and diluted loss per share Basic $ (1.94) $ (0.21) $ (0.17) Diluted (1.94) (0.21) (0.17) Weighted average number of shares outstanding Basic 31,445,962 29,305,828 21,873,594 Diluted 31,445,962 29,431,781 22,633,819 ZK INTERNATIONAL GROUP CO., LTD CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY FOR THE YEARS ENDED SEPTEMBER 30, 2023, 2022 AND 2021 (IN U.S. DOLLARS, EXCEPT SHARE DATA) Shares Additional paid-in capital Subscription Receivable Statutory surplus reserve Retained earnings(deficits) Accumulated other comprehensive income (loss) Non- controlling interests Total equity Balance at September 30, 2020 16,558,037 18,049,630 — 2,904,699 23,546,921 492,685 309,794 45,303,729 Issuance of common stock, net of offering costs 7,080,762 24,884,560 (125,000) 24,759,560 Common stock issued in connection with conversion of convertible notes 4,374,176 11,443,067 11,443,067 Issuance of common stock related to exercise of warrants 355,202 1,345,056 1,345,056 Stock-based compensation 550,000 9,542,783 9,542,783 Unearned Compensation (1,891,011) (1,891,011) Foreign currency translations 2,405,909 17,530 2,423,439 Net loss 9,903 (3,809,417) (2,757) (3,802,271) Balance at September 30, 2021 28,918,177 63,374,085 (125,000) 2,914,602 19,737,504 2,898,594 324,567 89,124,352 Stock incentive issuance 1,407,200 1,688,640 1,688,640 Stock issued in connection with conversion of convertible notes 67,563 116,781 116,781 Fair value change due to convertible notes extension 678,782 678,782 Stock-based compensation 5,603,615 5,603,615 Unearned Compensation (589,138) (589,138) Foreign currency translations (5,539,347) 34,962 (5,504,385) Net loss 261,954 (6,343,367) 27,147 (6,054,266) Balance at September 30, 2022 30,392,940 70,872,765 (125,000) 3,176,556 13,394,137 (2,640,753) 386,676 85,064,381 Stock-based compensation 2,599,800 1,839,733 1,839,733 Unearned Compensation 174,400 174,400 Foreign currency translations (550,232) 900 (549,332) Net loss (61,060,794) (229,596) (61,290,390) Balance at September 30, 2023 32,992,740 72,886,898 (125,000) 3,176,556 (47,666,657) (3,190,985) 157,980 25,238,792 ZK INTERNATIONAL GROUP CO., LTD CONSOLIDATED STATEMENTS OF CASH FLOWS (IN U.S. DOLLARS) For the year ended September 30, 2023 2022 2021 Cash Flows from Operating Activities: Net loss $ (61,290,390) $ (6,054,266) $ (3,802,271) Adjustments to reconcile net income to net cash used in operating activities: Depreciation expense 677,275 672,368 568,038 Amortization expense 298,431 830,481 481,763 Right of use assets — — (53,634) Bad debt expense and credit loss 17,897,334 227,837 92,032 Write-off of advance to suppliers — — 108,395 Deferred tax expenses 322,897 — 406,064 Gain on accounts receivable factoring, net of discount — (1,602,500) — Impairment on intangible assets and long-term investment 35,346,769 2,771,019 — Change in unrecognized tax benefits (823,340) (1,428,458) (918,038) Stock compensation expense 2,014,133 2,674,807 1,351,082 Interest expense of convertible notes 658,913 1,324,510 210,173 Interest expense of financing lease — — 44,458 Interest expense of accounts receivable factoring 359,051 1,151,453 — Changes in operating assets and liabilities: Accounts receivable 8,165,567 (12,059,620) 5,804,654 Other receivables and prepayments 349,612 (260,755) 1,345,520 Notes receivable (6,676) (53,853) 201,187 Inventories 2,870,541 (2,606,504) 2,021,789 Advance to suppliers 1,401,001 5,493,624 (8,297,301) Accounts payable (7,451,608) 8,803,924 (8,662,576) Notes payable (666,355) 762,986 (159,823) Accrued expenses and other current liabilities (1,918,915) 752,241 2,428,410 Accrued payroll and welfare 130,063 219,178 211,632 Advance from customers (923,844) (3,662,097) 3,162,961 Income tax payable — — (77,214) Long-term prepaid expenses 707,470 — — Lease liability - Operating lease (23,841) (28,595) 53,635 Net cash used in operating activities (1,905,912) (2,072,220) (3,479,064) Cash Flows from Investing Activities: Purchases of property, plant and equipment (656,178) (507,663) (114,319) Purchase of CIP (930,814) (12,666) (47,942) Purchases of intangible assets (707,470) (1,588,107) (1,983,812) Investment into CG Malta — — (25,000,000) Net cash used in investing activities (2,294,462) (2,108,436) (27,146,073) Cash Flows from Financing activities: Net proceeds released from (placed into) short-term investment 852,542 1,523,953 (2,228,301) Proceeds from short-term bank borrowings 21,486,396 31,113,044 31,203,129 Repayments of short-term bank borrowings (19,350,091) (34,501,465) (28,144,978) Net (repayment) receiving for due to related parties (920,690) 1,173,516 (280,313) Repayment of other borrowing — (279,004) (483,458) Proceeds from stock issuances — — 24,758,458 Proceeds from convertible notes issuances — — 14,071,908 Proceeds from stock warrants exercise — — 1,345,056 Net cash provided by (used in) financing activities 2,068,157 (969,956) 40,241,501 Effect of exchange rate changes on cash (439,515) (835,453) 227,305 Net (decrease) increase in cash, cash equivalents and restricted cash (2,571,733) (5,986,065) 9,843,669 Cash and cash equivalents and restricted cash at the beginning of period 7,617,139 13,603,204 3,759,535 Cash, cash equivalents and restricted cash at the end of period $ 5,045,406 $ 7,617,139 $ 13,603,204 Supplemental disclosures of cash flows information: Cash paid for income taxes $ 38,695 $ 87,473 $ 37,041 Cash paid for interest expenses $ 774,929 $ 976,091 $ 338,575 Non-cash transactions Offset between due from related parties and due to related parties balances $ 545,844 623,363 604,719 Intangible assets obtained in exchange for settlement of long-term deposit $ 707,470 749,252 —
HONG KONG, Aug. 13, 2024 /PRNewswire/ -- AWESum Care is pleased to announce that Mr. John Tsang, the former Financial Secretary, will serve as the first ambassador of the social enterprise. Mr Tsang has always been committed to promoting social welfare and firmly believes in the importance of Advance Care Planning. Mr Tsang visited and showed support for the booth of AWE Sum Care at the Golden Age Expo and Summit, which ended successfully on August 4.  Mr Tsang shared with us that when facing the uncertainty of the future, it is crucial for everyone to plan in advance. The three documents - Enduring Power of Attorney, Advance Medical Directive and Will can ensure that every individual can receive appropriate care according to their own wishes when needed. Mr Tsang said, "When facing the uncertainty of the future, it is crucial for everyone to plan in advance. The three documents - Enduring Power of Attorney (EPA), Advance Medical Directive (AMD) and Will can ensure that every individual can receive appropriate care according to their own wishes when needed." Three important documents of Advance Care Planning Enduring Power of Attorney (EPA): An EPA can be used to authorize one or more attorneys to manage property when one becomes unable to handle financial affairs on his or her own. Advance Medical Directive (AMD): An AMD is a written document and a medical choice that allows one to indicate the form of medical treatment not to be received in the future if one loses capacity due to terminal illness. Will: A will sets out how one's estate is to be distributed after his or her death. Mr Kim Chan, founder of AWESum Care, said, "We are very honored to invite Mr John Tsang as our first ambassador. His presence will greatly enhance the public's understanding and importance of advance care planning. We believe that through collaborative efforts, we can help more Hong Kong citizens to plan in advance, protecting everyone's rights and well-being." AWESum Care will continuously promote advance care planning, by providing relevant information and support, and helping all sectors of the society to understand and take action. We hope to ensure that everyone receives the most appropriate care when they need it. About social enterprise AWESum Care (DocPro Services Limited) AWESum Care is a social enterprise founded by lawyer Kim Chan. AWESum Care is technology-based and committed to providing a user-friendly platform for formulating legal documents independently. We actively apply the latest technological trends to ensure that AWESum Care is a platform that stays up to date, while meeting the needs of the aging social population and continuously improving service quality in terms of safety, convenience and user experience. Website：https://www.awesumcare.comFacebook page：安心三寶 AWESum CareInstagram：awesumcareDownload AWESum Care App：ios version 、google play store version For more information，please contact：安心三寶 AWESum CareTel：+852-9127 7273Email：info@awesumcare.hkWebsite：www.awesumcare.hk
香港2024年8月13日 /美通社/ -- 安心三寶 AWESum Care 欣然宣佈，前財政司司長曾俊華先生將擔任本社企的首位大使。曾俊華先生一直致力於推動社會福祉，並深信預設照護計劃（Advance Care Planning）的重要性。曾振華先生親臨安心三寶於黃金時代展覽的攤位支持，展覽於8月4日圓滿結束。  曾俊華先生表示在面對未來的不確定性時，提早做好規劃對每個人都至關重要。三寶文件——持久授權書、預設醫療指示和平安紙，能確保在需要時，每個人都能按照自己的意願得到適當的照護。 曾俊華先生表示：「在面對未來的不確定性時，提早做好規劃對每個人都至關重要。三寶文件——持久授權書、預設醫療指示和平安紙，能確保在需要時，每個人都能按照自己的意願得到適當的照護。」 預設照護計劃的三份重要文件 持久授權書：當失去行為能力無法自己處理財務事務時，可以以持久授權書授權一個或多個受權人管理財產。 預設醫療指示：預設醫療指示是一份書面文件，亦是一種醫療選擇，當身體面臨嚴重疾病或瀕臨生命終結時，可以做出不接受維生治療的決定。 平安紙：遺囑是一份法律文件，被用來規定在立囑人離世後，資產應如何分配。 安心三寶創辦人陳啟川律師表示：「我們非常榮幸能夠邀請到曾俊華先生擔任我們的首位大使。他的加入將大大提升公眾對預設照護計劃的認識和重視。我們相信，通過共同努力，可以幫助更多香港市民提前做好規劃，保障大家的權益和福祉。」 安心三寶 AWESum Care 將繼續致力於推廣預設照護計劃，提供相關的資訊和支持，幫助社會各界理解並採取行動，以確保每個人在需要時都能得到最合適的照護。 關於社企「安心三寶 」AWESum Care (DocPro Services Limited) 「安心三寶」是一家社會企業，由陳啟川律師創立。安心三寶以科技為基礎，致力於提供一個簡單易用的自主訂立法律文件平台。我們積極應用最新的科技趨勢，以確保安心三寶成為一個與時並進的平台，同時滿足社會人口老化的需求，不斷提升在安全性、便利性和用戶體驗方面的服務品質。 網站：https://www.awesumcare.comFacebook 專頁：安心三寶 Awesum CareInstagram：awesumcare下載安心三寶App：ios版本 、google play store版本 如需更多資訊，請聯絡： 安心三寶 AWESum Care電話：+852-9127 7273電郵：info@awesumcare.hk網站：www.awesumcare.hk
Leading Victorian healthcare network integrates oncology and EHR solutions to deliver more informed care across its locations AUSTIN, Texas and VICTORIA, Australia, Aug. 13, 2024 /PRNewswire/ -- Leading Victorian healthcare network, Alfred Health, has extended its long-standing Oracle Health footprint with Oracle's Oncology electronic health record (EHR) solutions to support care for cancer patients. By moving from paper-based processes to digitized records, primary care and specialty clinicians across Alfred Health's in and out-patient locations now have a single view of each patient's complete medical history. The integrated records not only promise to help save physicians' valuable time, but also help improve the safety and quality of care with a clear view into cancer patient's treatment plans, therapies, and current medications. "Completely digitizing and making cancer treatment information easily available in our EHR makes guiding the overall treatment plan for patients more efficient," said Erica Tong, chief pharmacy information officer, Alfred Health. Streamlining technology to further advance careBeyond just record access, Alfred Health is leveraging Oracle EHR to help connect Alfred Health patients with more cancer clinical trial opportunities. Trials can be viewed directly in the EHR so clinicians can easily identify possible therapies and eligibility for patients. If a patient is already involved in a trial, their progress and details are tracked and documented within their overall health record. Pharmacist processes are streamlined as well, helping prepare cancer patient treatment plans in more timely fashion, with order information being pushed directly from the EHR into the pharmacy management system. Barcodes are also generated for each treatment so nurses can scan to confirm the prescribed medication is going to the right patient and in the correct dose. Prior to these cancer treatment enhancements, Alfred Health was the first hospital in the region to implement electronic prescriptions (eprescribe) within a hospital EHR to help make prescribing and dispensing medications more efficient and accurate. Patients now can receive prescriptions as a barcode via SMS or e-mail to be presented to a community pharmacy for dispensing. "Alfred Health has long been at the forefront of innovation in adopting technologies that break down the barriers to safer and more efficient care," said Seema Verma, executive vice president and general manager, Oracle Health and Life Sciences. "This recent implementation is especially unique and special as it not only helps caregivers more effectively treat cancer patients and manage medications over time through better access to information, but also helps them find and enroll in new, potentially life-saving therapies all within the EHR." Alfred Health also worked with Oracle to enable support of the national Safescript program, a centralized database that allows prescribing and dispensing records for certain high-risk medicines to be transmitted in real-time. By integrating access to the national database with the Oracle EHR, clinicians can view prescription history directly in their existing workflows to help facilitate the early identification, treatment, and support for patients developing signs of dependence. Alfred Health also was one of the first hospitals in Australia to digitize immunization records sharing from the Oracle EHR to the national registry to help ensure vaccinations are consistently and accurately administered and tracked within any venue of care. Learn more about how Oracle Health is supporting healthcare customers in Australia at https://www.oracle.com/au/health/. About Alfred HealthAlfred Health provides a comprehensive range of healthcare services in Victoria through three hospital campuses, a large network of community programs and many statewide services. About OracleOracle offers integrated suites of applications plus secure, autonomous infrastructure in the Oracle Cloud. For more information about Oracle (NYSE: ORCL), please visit us at www.oracle.com. TrademarksOracle, Java, MySQL and NetSuite are registered trademarks of Oracle Corporation. NetSuite was the first cloud company—ushering in the new era of cloud computing. Logo - https://mma.prnasia.com/media2/1766551/Oracle_Logo_Logo.jpg?p=medium600
JUPITER, Fla., Aug. 13, 2024 /PRNewswire/ -- Bodvár Rosé, the renowned producer of premium rosé wines, proudly celebrates a significant milestone with Turkish producer and DJ Furkan Sert for their hit song "Bodvár." Since its release, the sophisticated dance track has amassed over three million streams on Spotify, becoming a viral sensation globally. This unique partnership, initiated a year ago, has merged the worlds of music and wine, reflecting Bodvár Rosé's mission to create unforgettable experiences and promote a lifestyle of elegance, joy, and togetherness. Bodvár Rosé celebrates three million streams on Spotify for the hit song “Bodvár” "Bodvár Rosé is synonymous with the modern art of living well," said Bodvár Hafström, Founder of Bodvár Rosé. "Our mission is to create moments of joy and connection, whether it's through sharing a bottle of our premium rosé or enjoying the harmonious blend of music and wine. Our collaboration with Furkan has amplified this mission, resonating with audiences who appreciate the finer things in life." Bodvár Rosé, which just announced the launch of their first non-alcoholic rosé, Bodvár No. 0, continues to break new ground in the industry. This latest collaboration has expanded the brand's global reach, connecting with music lovers worldwide and enriching the Bodvár Rosé experience. The company continues to solidify its position as a leader in the luxury wine market and a pioneer in innovative brand partnerships. The work with Furkan Sert, celebrated for his distinctive blend of Deep House, Indie Dance, and Oriental House, naturally aligns with Bodvár Rosé's mission and has allowed the brand to extend its reach beyond the vineyards into beach clubs in Europe and beyond. "Working with Bodvár Rosé has been an inspiring journey," said Sert. "Their dedication to crafting beautiful moments through their rosés perfectly complements my music. Together, we've created something special that celebrates the art of living and enjoying life to the fullest." For more information, please visit: www.bodvarrose.com About Bodvár RoséFounded in 2007 in the sun-drenched vineyards of Provence, Bodvár Rosé is a distinguished producer of premium rosé wines. With a dedication to quality and elegance, our award-winning rosés are celebrated for their crisp, fresh flavors and ability to bring the essence of the French Riviera to any occasion. Each bottle is crafted to capture the joy and romance of southern France, making every sip an invitation to experience the luxury and beauty of a Bodvár moment. Join us in celebrating life's pleasures at selected restaurants, hotels, and retailers worldwide. Discover more about Bodvár Rosé and our commitment to creating memories at www.bodvarrose.com.
STAMFORD, Conn., Aug. 13, 2024 /PRNewswire/ -- Emeren Group Ltd ("Emeren" or the "Company") (www.emeren.com) (NYSE: SOL), a leading global solar project developer, owner, and operator, today announced that it will report its unaudited financial results for the second quarter ended June 30, 2024 after the U.S. stock market close on Tuesday, August 20, 2024. The Company will hold a conference call to discuss the financial results at 5:00 p.m. U.S. Eastern Time on Tuesday, August 20, 2024. What: Emeren Group Ltd Second Quarter (ended June 30, 2024) Earnings Call When: 5:00 p.m. U.S. Eastern Time on Tuesday, August 20, 2024 Webcast:https://edge.media-server.com/mmc/p/vtruwnm5 Participant Online Registration: https://register.vevent.com/register/BI3322e571bd1c41aaa3ec696353562074 Please register in advance to join the conference call using the link provided below and dial in 10 minutes before the call is scheduled to begin. Conference call access information will be provided upon registration. Additionally, a live and archived webcast of the conference call will be available on the Investor Relations section of Emeren Group Ltd's website at https://ir.emeren.com/. About Emeren Group Ltd Emeren Group Ltd (NYSE: SOL), a renewable energy leader, showcases a comprehensive portfolio of solar projects and Independent Power Producer (IPP) assets, complemented by a significant global Battery Energy Storage System (BESS) capacity. Specializing in the entire solar project lifecycle — from development through construction to financing — we excel by leveraging local talent in each market, ensuring our sustainable energy solutions are at the forefront of efficiency and impact. Our commitment to enhancing solar power and energy storage underlines our dedication to innovation, excellence, and environmental responsibility. For more information, go to www.emeren.com. For investor and media inquiries, please contact: Emeren Group Ltd - Investor Relationsir@emeren.com The Blueshirt Group Gary Dvorchak+1 (323) 240-5796gary@blueshirtgroup.co
A12 藝術空間
請先登入後才能發佈新聞。
還不是會員嗎？立即 加入台灣產經新聞網會員 ，使用免費新聞發佈服務。 （服務項目） （投稿規範）
